The most common gene alterations in the 64 primary pancreatic cancer were KRAS (96.9%), TP53 (81.2%), CDKN2A (35.9%), and SMAD4 (15.6%) (Figure 3A). This evidence concerns the gene SMAD4 and pancreatic neoplasm.